I am not sure if GBSN will follow AEZS or not.
But next whole week will be interesting for AEZS, price may pass $1.
1, although we have cashless B warrant threat, new comers don't know that because that information hides in deep.
2, If people simply search AEZS from Yahoo finance, they will find AEZS has $45 MM cash, no debt, 182MM shares outstanding, muti-phase 3 drugs on trial. And early Oct. will get update. So, people will easily evaluate AEZS above $200MM market capital. That means we will pass $1.
3, If people have AEZS shares already and want to take profit they should already do so because last Friday AEZS increased 130+%. So, the newcomers all will be net buyers.
4, Wallstreet and main medias all publish positive news and muti-dollars target on AEZS based on Friday AEZS volume/price action. These articles will reach many investors on the weekend.
5, Based on nature of AEZS bio-pharm, a bio-pharm stock price will easily decease 90% when it is in downtrend, but it also will easily increase 900% when it is in uptrend.
